We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$1.59B
AUM Growth
+$64.1M
Cap. Flow
+$43.9M
Cap. Flow %
2.76%
Top 10 Hldgs %
38.94%
Holding
386
New
11
Increased
148
Reduced
18
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 26.6%
2 Financials 18.49%
3 Communication Services 15.82%
4 Consumer Discretionary 12.71%
5 Healthcare 12.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VISN
376
Vistance Networks Inc
VISN
$2.63B
-7,000
Closed -$110K
CTAS icon
377
Cintas
CTAS
$81.1B
-8,800
Closed -$522K
GGAL icon
378
Galicia Financial Group
GGAL
$7.46B
-22,000
Closed -$781K
JNJ icon
379
Johnson & Johnson
JNJ
$631B
-64,800
Closed -$9.03M
MAA icon
380
Mid-America Apartment Communities
MAA
$15.4B
-2,400
Closed -$283K
SAGE
381
DELISTED
Sage Therapeutics
SAGE
-55,595
Closed -$10.2M
VMC icon
382
Vulcan Materials
VMC
$37B
-3,500
Closed -$481K
VRSN icon
383
VeriSign
VRSN
$26.5B
-2,900
Closed -$607K
TSS
384
DELISTED
Total System Services, Inc.
TSS
-3,903
Closed -$501K
RHT
385
DELISTED
Red Hat Inc
RHT
-8,366
Closed -$1.57M
FDC
386
DELISTED
First Data Corporation
FDC
-15,000
Closed -$406K

Similar funds

E. Ohman J:or Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, E. Ohman J:or Asset Management held 386 positions worth $1.59B, up 4.2% from $1.52B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

E. Ohman J:or Asset Management's Q3 2019 filing shows 11 new, 148 increased, 18 reduced and 14 closed positions. Its largest new stake was Centene: 347,989 shares worth $15.1M. The largest sale was Regeneron Pharmaceuticals, an estimated $12.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Communication Services.

  • E. Ohman J:or Asset Management's largest Q3 2019 buy was Centene: 347,989 shares worth $15.1M.
  • E. Ohman J:or Asset Management added most to BioMarin Pharmaceuticals in Q3 2019, an estimated $12.8M increase.
  • E. Ohman J:or Asset Management's biggest Q3 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $12.3M.
  • E. Ohman J:or Asset Management fully exited Sage Therapeutics in Q3 2019, selling an estimated $10.2M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 39% of its $1.59B portfolio in Q3 2019.
  • E. Ohman J:or Asset Management opened 11 new positions and closed 14 in Q3 2019.
  • E. Ohman J:or Asset Management's portfolio value rose 4.2% quarter-over-quarter to $1.59B.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2019, filed 5 Apr 2024.